Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
A widely cited price-target call for PepsiCo pairs a $168.86 target with a $138.68 reference price, implying roughly 22% potential gains over the next 12 months, according to a market commentary published June 30.
THE APEX TIMES
THE APEX TIMES
The company is betting that newer launches and expanded indications can broaden revenue streams beyond its best-known GLP-1 medicines, Mounjaro and Zepbound.
THE APEX TIMES
The company began reintroducing its MD-11 freighters after grounding the entire fleet in November, with CEO Raj Subramaniam saying the carrier expects to restore full capacity before the busiest period of the year.
THE APEX TIMES
A report from Yahoo Finance says Microsoft is expanding its security ecosystem through additional partnerships and AI features, underscoring how security could become a larger contributor to future cloud revenues as companies shift budgets toward risk reduction.
THE APEX TIMES
A new investor-focused roundup points to three dates in July that could move attention for The Walt Disney Company, including progress on a marquee attraction update, the return of Dwayne Johnson in a major role, and additional theme-park operational updates.
THE APEX TIMES
A new consortium-backed stablecoin framework, announced Tuesday by partners including Visa, Mastercard and Coinbase, aims to widen payments and issuance using a shared standard rather than a single issuer.
THE APEX TIMES
The EV maker is expected to publish second-quarter delivery figures soon, and investors are watching whether growth outside the United States can offset a weaker U.S. trend.
THE APEX TIMES
In a new Verizon parenting guide, the telecom company presents four interactive challenges designed to help children evaluate online content and make sense of what they see on screens.
THE APEX TIMES
Eli Lilly and Regeneron are among the first companies selected for the FDA’s PreCheck facility scheme, a pilot designed to add checks to the flow of medicines before products reach patients.
